Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before surgery, an expected average of 15 min
Awards & highlights
Study Summary
This trial is testing a new system to help guide surgeons during laparoscopic surgery, and collecting feedback on its use.
Eligible Conditions
- Laparoscopic Cholecystectomy
- Liver Ablation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before surgery, an expected average of 15 min
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before surgery, an expected average of 15 min
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
System set-up time
Usability
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients using LapAR systemExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LapAR
2020
N/A
~20
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,656 Total Patients Enrolled
IGI Technologies, Inc.Industry Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
Raj ShekharLead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any empty slots in this clinical trial that need to be filled?
"The study is still enrolling patients, as evidenced by the most recent edit to the listing on clinicaltrials.gov (2/22/2021). The posting went up on 9/29/2020."
Answered by AI
Is this trial open to patients who are under the age of 80?
"The target recruitment pool for this trial are minors aged one year or older but less than 18."
Answered by AI
Share this study with friends
Copy Link
Messenger